Genomtec S.A. (GMT.WA)

PLN 8.68

(1.17%)

EBITDA Summary of Genomtec S.A.

Genomtec S.A.'s latest annual EBITDA in 2023 was -7.75 Million PLN , up 19.94% from previous year.
Genomtec S.A.'s latest quarterly EBITDA in 2024 Q2 was -2.79 Million PLN , down -35.55% from previous quarter.
Genomtec S.A. reported an annual EBITDA of -11.05 Million PLN in 2022, down -10.87% from previous year.
Genomtec S.A. reported an annual EBITDA of -6.57 Million PLN in 2021, up 29.51% from previous year.
Genomtec S.A. reported a quarterly EBITDA of -2.79 Million PLN for 2024 Q2, down -35.55% from previous quarter.
Genomtec S.A. reported a quarterly EBITDA of -2.6 Million PLN for 2023 Q3, down -54.11% from previous quarter.

Annual EBITDA Chart of Genomtec S.A. (2023 - 2019)

Historical Annual EBITDA of Genomtec S.A. (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-7.75 Million PLN	19.94%
2022	-11.05 Million PLN	-10.87%
2021	-6.57 Million PLN	29.51%
2020	-10.67 Million PLN	-417.27%
2019	-1.44 Million PLN	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-2.38 Million PLN	-32.82%
2024 Q2	-2.79 Million PLN	-35.55%
2023 Q3	-2.6 Million PLN	-54.11%
2023 Q1	-1.89 Million PLN	66.61%
2023 Q4	-2.75 Million PLN	-5.53%
2023 Q2	-1.69 Million PLN	10.77%
2023 FY	- PLN	19.94%
2022 Q2	-1.68 Million PLN	12.74%
2022 Q1	-1.92 Million PLN	-19.34%
2022 FY	- PLN	-10.87%
2022 Q4	-5.67 Million PLN	-236.6%
2022 Q3	-1.68 Million PLN	-0.2%
2021 Q4	-1.61 Million PLN	-31.31%
2021 FY	- PLN	29.51%
2021 Q3	-1.23 Million PLN	45.41%
2021 Q2	-2.25 Million PLN	0.0%
2020 FY	- PLN	-417.27%
2019 FY	- PLN	0.0%

Peer EBITDA Comparison of Genomtec S.A.

Name	EBITDA	EBITDA Difference
Adiuvo Investments S.A.	-5.08 Million PLN	-52.527%
Medinice S.A.	-4.72 Million PLN	-64.079%
Medicalgorithmics S.A.	2.23 Million PLN	447.025%
Synektik Spólka Akcyjna	125.43 Million PLN	106.183%